Microbot Medical (MBOT) Trading Down 0%

Microbot Medical Inc (NASDAQ:MBOT)’s share price traded down 0% during mid-day trading on Wednesday . The stock traded as low as $0.75 and last traded at $0.89. 432,889 shares were traded during mid-day trading, a decline of 55% from the average session volume of 960,488 shares. The stock had previously closed at $0.89.

Several equities analysts have issued reports on the stock. Ladenburg Thalmann Financial Services assumed coverage on shares of Microbot Medical in a report on Wednesday, January 31st. They issued a “buy” rating and a $1.75 price target on the stock. ValuEngine raised shares of Microbot Medical from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

In other news, Director Yoseph Bornstein sold 45,000 shares of Microbot Medical stock in a transaction on Tuesday, November 21st. The shares were sold at an average price of $1.21, for a total transaction of $54,450.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold 272,990 shares of company stock valued at $291,894 over the last quarter. Insiders own 31.83% of the company’s stock.

A hedge fund recently raised its stake in Microbot Medical stock. Vanguard Group Inc. lifted its stake in shares of Microbot Medical Inc (NASDAQ:MBOT) by 252.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 159,992 shares of the biotechnology company’s stock after buying an additional 114,561 shares during the period. Vanguard Group Inc. owned approximately 0.43% of Microbot Medical worth $228,000 at the end of the most recent quarter. Institutional investors and hedge funds own 4.67% of the company’s stock.

WARNING: This story was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://sportsperspectives.com/2018/02/08/microbot-medical-mbot-trading-down-0.html.

About Microbot Medical

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply